High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and interconnecting Mechanisms

被引:29
|
作者
Schuett, Katharina Andrea [1 ]
Lehrke, Michael [1 ]
Marx, Nikolaus [1 ]
Burgmaier, Mathias [1 ]
机构
[1] Univ Hosp RWTH Aachen, Dept Internal Med 1, Aachen, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
关键词
atherosclerosis; type 2 diabetes mellitus; systemic lupus erythematosus; rheumatoid arthritis; coagulation; inflammation; cardiovascular disease; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORONARY-HEART-DISEASE; DIET-INDUCED OBESITY; RHEUMATOID-ARTHRITIS; TISSUE FACTOR; INSULIN-RESISTANCE; EXTRACELLULAR HISTONES; MYOCARDIAL-INFARCTION; PLATELET ACTIVATION; ADIPOSE-TISSUE;
D O I
10.3389/fimmu.2015.00591
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiovascular disease is the leading cause of death in the Western world with an increase over the last few decades. Atherosclerosis with its different manifestations in the coronary artery tree, the cerebral, as well as peripheral arteries is the basis for cardiovascular events, such as myocardial infarction, stroke, and cardiovascular death. The pathophysiological understanding of the mechanisms that promote the development of vascular disease has changed over the last few decades, leading to the recognition that inflammation and inflammatory processes in the vessel wall are major contributors in atherogenesis. In addition, a subclinical inflammatory status, e.g., in patients with diabetes or the presence of a chronic inflammatory disease, such as rheumatoid arthritis, have been recognized as strong risk factors for cardiovascular disease. The present review will summarize the different inflammatory processes in the vessel wall leading to atherosclerosis and highlight the role of inflammation in diabetes and chronic inflammatory diseases for cardiovascular morbidity and mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The cardiovascular polypill in high-risk patients
    Lafeber, Melvin
    Spiering, Wilko
    Singh, Kavita
    Guggilla, Rama K.
    Patil, Vinodvenkatesh
    Webster, Ruth
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (06) : 1234 - 1242
  • [2] Rationality and Methods - Registry of Clinical Practice in High-risk Cardiovascular Patients
    Piva e Mattos, Luiz Alberto
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (01)
  • [3] Managing high-risk atrial fibrillation patients with multiple comorbidities
    Gregory Y. H. Lip
    International Journal of Arrhythmia, 24 (1)
  • [4] Concurrent Medication Adherence in Hypertensive Patients With High-Risk Comorbidities
    Oh, Oonjee
    Lee, Kyoung Suk
    JOURNAL OF CARDIOVASCULAR NURSING, 2024, 39 (05) : 477 - 487
  • [5] Cardiovascular protection: a breakthrough for high-risk patients
    Boehm, Michael
    Mahfoud, Felix
    Werner, Christian
    Teo, Koon
    Baumhaekel, Magnus
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0F) : F19 - F26
  • [6] Cardiovascular protection: a breakthrough for high-risk patients?
    Ferrari, Roberto
    JOURNAL OF HYPERTENSION, 2009, 27 : S37 - S40
  • [8] PREOPERATIVE OPTIMIZATION OF PATIENTS WITH HIGH-RISK COMORBIDITIES: A REVIEW OF PREHABILITATION INTERVENTIONS
    Mauricio-Lee, J.
    Sokolov, D.
    Gupta, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP414 - NP414
  • [9] CLINICAL EFFECTIVENESS OF PACEMAKER IN HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASES: A SYSTEMATIC REVIEW AND METANALYSIS
    Seshu, P.
    Kachroo, D. K.
    Sharma, J.
    Rm, K.
    Varalakshmi, G.
    VALUE IN HEALTH, 2023, 26 (06) : S14 - S15
  • [10] Impact of comorbidities on heart rate variability in patients with high cardiovascular risk
    Gadaleta, M.
    Mason, F.
    Steinhubl, S. R.
    Quer, G.
    EUROPEAN HEART JOURNAL, 2023, 44